Latest filing published 13 Nov 2023 for Zimmer Biomet Holdings, INC., €209k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +1.8%Entry US$108.07 · Close at T+365 US$109.97
- +11.2%Entry US$120.50 · Close at T+365 US$134.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Syed A. Jafry: trading record in brief
On July 27, 2020, Syed A. Jafry filed three sales at Thermo Fisher Scientific Inc. on the same day: EUR 2,190,204, EUR 1,443,066 and EUR 1,363,643. Across the whole record, 7 sales weigh EUR 7,232,090, with a median of EUR 1,138,383.
There are also 2 purchases, both at Zimmer Biomet Holdings, Inc., where Syed A. Jafry is a Director: EUR 212,447 on March 1, 2019 and EUR 208,807 on November 9, 2023, which is EUR 421,254. Purchases make up 22% of open-market trades. At Thermo Fisher, the listed role is Sr. Vice President.
The 27 filings cover trades from March 1, 2019 to November 9, 2023, with 14 share grants and 4 option exercises on top. Nearly everything is concentrated in 2020: 20 filings, against 5 in 2021 and a single one in 2019 as in 2023.
Jafry's own market trades within 30 days of colleagues at Thermo Fisher Scientific Inc. number 7, 7 and 7, all in the same direction. Colleagues in order: Jim P. Manzi, Marc N. Casper and Mark Stevenson.
Companies and markets linked to Syed A. Jafry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,135 shares@ US$104.75100.0% of flowCommon StockSEC:0001062993-23-020641:0Canonical exit: 7 Feb 2024 (T+90)
- 790 shares@ US$451.472.3% of flowCommon StockSEC:0001127602-21-008321:0
- 1,139 shares@ US$450.083.3% of flowCommon StockSEC:0001127602-21-008321:1
- 471 shares@ US$458.811.4% of flowCommon StockSEC:0001127602-21-007949:1
- 4,769 shares0Common StockSEC:0001127602-21-007949:0
- 825 shares0Common StockSEC:0001127602-21-007949:2
- 586 shares@ US$420.531.8% of flowCommon StockSEC:0001127602-20-024474:0
- 692 shares@ US$424.482.1% of flowCommon StockSEC:0001127602-20-024474:1
- 181 shares@ US$422.290.5% of flowCommon StockSEC:0001127602-20-024319:0
- 405 shares@ US$425.651.2% of flowCommon StockSEC:0001127602-20-024319:1
- 5,638 shares@ US$129.775.3% of flowCommon StockSEC:0001127602-20-022203:0
- 2,100 shares@ US$414.326.3% of flowCommon StockSEC:0001127602-20-022203:1
- 3,225 shares@ US$415.449.6% of flowCommon StockSEC:0001127602-20-022203:2
- 313 shares@ US$415.880.9% of flowCommon StockSEC:0001127602-20-022203:3
- 6,200 shares@ US$157.687.0% of flowCommon StockSEC:0001127602-20-022203:4
- 6,200 shares@ US$415.7618.5% of flowCommon StockSEC:0001127602-20-022203:5
- 4,575 shares@ US$210.686.9% of flowCommon StockSEC:0001127602-20-022203:6
- 3,875 shares@ US$414.1711.5% of flowCommon StockSEC:0001127602-20-022203:7
- 700 shares@ US$415.152.1% of flowCommon StockSEC:0001127602-20-022203:8
- 4,100 shares@ US$253.997.5% of flowCommon StockSEC:0001127602-20-022203:9
- 4,100 shares@ US$414.2412.2% of flowCommon StockSEC:0001127602-20-022203:10
- 1,154 shares@ US$297.082.7% of flowCommon StockSEC:0001127602-20-008371:0
- 582 shares@ US$309.631.4% of flowCommon StockSEC:0001127602-20-008155:2
- 957 shares@ US$309.162.3% of flowCommon StockSEC:0001127602-20-008155:3
- 2,725 shares0Common StockSEC:0001127602-20-008155:0
25 of 27 declarations
